Envestnet Asset Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
Envestnet Asset Management's CDLX Position: Q3 2021 in Review
Envestnet Asset Management sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 268 shares — an estimated $340K sold.
Envestnet Asset Management first reported a position in CDLX in Q4 2020 and held it in 2 quarters. The position peaked at $340K in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.
- Envestnet Asset Management reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
- Envestnet Asset Management sold 268 Cardlytics shares in Q3 2021, an estimated $340K.
- Envestnet Asset Management first reported a position in Cardlytics in Q4 2020 and held it in 2 quarters.
- Envestnet Asset Management's Cardlytics position peaked at $340K in Q2 2021.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.
Based on Envestnet Asset Management's 13F filing for Q3 2021, filed 7 Oct 2021.